Making brain function measurable and actionable at scale
Beacon Biosignals is a neurotechnology company using AI-powered EEG analytics to accelerate drug development for neurological and psychiatric disorders. Its platform analyzes real-world brain data from clinical trials, helping biopharma companies measure treatment efficacy and identify biomarkers across epilepsy, sleep disorders, and other conditions.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNov 2025
Nov 2021
Jan 2020
Create a free account to see which investors have funded this company.
Create Free Account
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
